language-icon Old Web
English
Sign In

Inolimomab

Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the interleukin-2 receptor. Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the interleukin-2 receptor.

[ "Hematopoietic stem cell transplantation", "Monoclonal antibody", "steroid refractory", "Acute graft versus host disease" ]
Parent Topic
Child Topic
    No Parent Topic